Table 1. Modulatory Effect of the Library of Small Molecule Analogues on TLR-Dependent Cytokine Productiona.
(A) phosphonates and phosphates | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
SMA | X | Y | n | Z | LPS IL-12 | LPS IL-6 | BLP IL-12 | BLP IL-6 | CPG IL-12 | CPG IL-6 |
5a | CH2PO3– | 4-Br | 2 | NMe3+ | ↓ | ↑ | ↓ | |||
5b | CH2PO3– | 4-Br | 2 | NMe2 | ↑ | ↑ | ||||
5c | CH2PO3– | 4-Me | 2 | NMe2 | ↑ | |||||
5d | CH2PO3– | 4-NO2 | 2 | NMe3+ | ↑ | ↑ | ||||
5e | CH2PO3– | 4-Me | 2 | NMe2 | ↑ | ↑ | ||||
6 | OPO3– | 4-BOCNH | 3 | NMe2 | ↑ | ↑ |
(B) sulfones | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
SMA | X | Y | n | Z | LPS IL-12 | LPS IL-6 | BLP IL-12 | BLP IL-6 | CpG IL-12 | CpG IL-6 |
11a | CH2SO2 | 4-Br | 2 | Me2N | ↓ | ↓ | ↓ | ↓ | ↓ | |
11b | CH2SO2 | 4-Me | 2 | Me2N | ↓ | ↓ | ||||
11c | CH2SO2 | 4-Me | 2 | pyrrol | ↓ | ↓ | ↓ | ↓ | ||
11d | CH2SO2 | 4-Br | 2 | pyrrol | ↓ | |||||
11e | CH2SO2 | 3-F | 2 | NMe2 | ↑ | ↑ | ||||
11f | CH2SO2 | 3-F | 2 | diam | ||||||
11g | CH2SO2 | 3-F | 2 | morph | ↑ | |||||
11h | CH2SO2 | 3-F | 2 | pyrrol | ↑ | ↓ | ||||
11i | CH2SO2 | 4-F | 2 | NMe2 | ↓ | ↓ | ||||
11j | CH2SO2 | 4-F | 2 | morph | ↓ | ↑ | ↑ | |||
11k | CH2SO2 | 4-F | 2 | pyrrol | ↑ | ↓ | ||||
11l | CH2SO2 | 4-F | 2 | diam | ↓ | |||||
11m | CH2SO2 | 3-F | 2 | S-2-Me-but | ||||||
11n | CH2SO2 | 3-F | 2 | R-2-Me-but | ↓ | ↓ | ||||
11o | CH2SO2 | 4-Br | 2 | S-2-Me-but | ↓ | |||||
11p | CH2SO2 | 4-Br | 2 | R-2-Me-but | ||||||
12a | CH2SO2 | 4-Br | 2 | Me3N+ | ||||||
12b | CH2SO2 | 4-Me | 2 | Me3N+ | ↓ | ↓ | ↓ | ↓ | ||
12c | CH2SO2 | 4-Me | 2 | pyrrol Me+ | ↓ | ↓ | ||||
12d | CH2SO2 | 4-Br | 2 | pyrrol Me+ | ↓ | ↓ | ↓ | |||
16a | CH2SO2 | 4-Br | 3 | pyrrol | ||||||
16b | CH2SO2 | 4-Br | 3 | NMe2 | ↓ | |||||
16c | CH2SO2 | 4-Br | 3 | morph | ↑ | ↓ | ||||
16d | CH2SO2 | 4-Me | 3 | pyrrol | ||||||
16e | CH2SO2 | 4-Me | 3 | NMe2 | ||||||
16f | CH2SO2 | 4-Me | 3 | morph | ||||||
17a | CH2SO2 | 4-Br | 3 | morph Me+ | ↑ | |||||
17b | CH2SO2 | 4-Br | 3 | Me3N+ | ↓ | ↓ | ||||
17c | CH2SO2 | 4-Br | 3 | pyrrol Me+ | ||||||
17d | CH2SO2 | 4-Me | 3 | pyrrol Me+ | ||||||
17e | CH2SO2 | 4-Me | 3 | Me3N+ | ||||||
18a | SO2 | H | 2 | diam | ↑ | |||||
18b | SO2 | H | 2 | thiomorph | ↓ | ↓ | ↑ | |||
18c | SO2 | H | 2 | morph | ↑ | ↓ | ||||
18d | SO2 | H | 2 | pyrrol | ↑ | ↓ | ||||
18e | SO2 | H | 2 | R-2-Me-but | ↑ | ↑ | ||||
18f | SO2 | H | 2 | S-2-Me-but | ||||||
18g | SO2 | H | 2 | diam (−Me) | ||||||
18h | SO2 | H | 2 | n-Pr | ↑ | ↑ | ↓ | ↓ | ||
18i | SO2 | H | 2 | i-Pr | ↓ | |||||
18j | SO2 | H | 2 | 3-OH-n-Pr | ↑ | ↑ | ↓ | |||
18k | SO2 | H | 2 | t-Bu | ↑ | ↓ | ||||
18l | SO2 | H | 2 | 4-Me-pip |
(C) sulfonamides
and carboxamides | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
SMA | X | Y | n | Z | LPS IL-12 | LPS IL-6 | BLP IL-12 | BLP IL-6 | CpG IL-12 | CpG IL-6 |
19a | CH2SO2NH | H | 2 | NMe2 | ↑ | |||||
19b | CH2SO2NH | H | 2 | pyrrol | ||||||
19c | CH2SO2NH | H | 2 | morph | ||||||
19e | CH2SO2NH | 4-Br | 2 | NMe2 | ↑ | ↑ | ||||
19d | CH2SO2NH | 4-Br | 2 | pyrrol | ↑ | |||||
19f | CH2SO2NH | 4-Br | 2 | morph | ↑ | ↑ | ||||
19g | CH2SO2NH | 4-F | 2 | NMe2 | ↑ | ↑ | ||||
19h | CH2SO2NH | 4-F | 2 | pyrrol | ↑ | ↑ | ↑ | ↑ | ||
19i | CH2SO2NH | 4-F | 2 | morph | ↑ | ↑ | ||||
19j | CH2SO2NH | 4-Me | 2 | NMe2 | ↑ | |||||
19k | CH2SO2NH | 4-Me | 2 | pyrrol | ||||||
19l | CH2SO2NH | 4-Me | 2 | morph | ||||||
19m | CH2SO2NH | 4-NO2 | 2 | NMe2 | ↓ | |||||
19n | CH2SO2NH | 4-NO2 | 2 | pyrrol | ||||||
19o | CH2SO2NH | 4-NO2 | 2 | morph | ||||||
19p | CH2SO2NH | 4-Br | 3 | NMe2 | ||||||
19q | CH2SO2NH | 4-NO2 | 3 | NMe2 | ↓ | |||||
19r | CH2SO2NH | 4-Me | 3 | NMe2 | ||||||
19s | CH2SO2NH | 4-F | 3 | NMe2 | ||||||
19t | CH2SO2NH | H | 3 | NMe2 | ↑ | |||||
19u | CH2SO2NH | 2-naphthyl | 2 | morph | ↓ | ↓ | ↓ | ↓ | ||
19v | CH2SO2NH | 2-naphthyl | 2 | pyrrol | ↓ | |||||
19w | CH2SO2NH | 2-naphthyl | 2 | NMe2 | ||||||
19x | CH2SO2NH | 4-stilbenyl | 2 | NMe2 | ↓ | |||||
21a | CH2NHSO2 | H | 2 | pyrrol | ||||||
21b | CH2NHSO2 | H | 2 | morph | ||||||
21c | CH2NHSO2 | H | 2 | NMe2 | ↑ | |||||
21d | CH2NHSO2 | 4-Br | 2 | morph | ||||||
21e | CH2NHSO2 | 4-Br | 2 | pyrrol | ↑ | ↑ | ↑ | ↑ | ||
21f | CH2NHSO2 | 4-Br | 2 | NMe2 | ↑ | |||||
21g | CH2NHSO2 | 4-Me | 2 | morph | ||||||
21h | CH2NHSO2 | 4-Me | 2 | pyrrol | ↑ | ↑ | ↑ | |||
21i | CH2NHSO2 | 4-Me | 2 | NMe2 | ↑ | ↑ | ||||
21j | CH2NHSO2 | 4-NO2 | 2 | morph | ||||||
21k | CH2NHSO2 | 4-NO2 | 2 | pyrrol | ||||||
21l | CH2NHSO2 | 4-NO2 | 2 | NMe2 | ↓ | ↓ | ↓ | ↓ | ↓ | |
21m | CH2NHSO2 | 4-F | 2 | morph | ↓ | ↓ | ↓ | ↓ | ||
21n | CH2NHSO2 | 4-F | 2 | pyrrol | ↓ | ↓ | ↓ | |||
21o | CH2NHSO2 | 4-F | 2 | NMe2 | ↓ | |||||
21p | CH2NHSO2 | 4-Me | 2 | diam | ↓ | ↓ | ↓ | ↓ | ||
21q | CH2NHSO2 | 4-Br | 2 | diam | ↓ | ↓ | ↓ | |||
21r | CH2SO2NH | ‘coumarin’ | 2 | morph | ↓ | ↓ | ||||
21s | CH2SO2NH | ‘coumarin’ | 2 | pyrrol | ↓ | ↓ | ||||
21t | CH2SO2NH | ‘coumarin’ | 2 | NMe2 | ↓ | ↓ | ||||
23a | NHSO2 | H | 2 | NMe2 | ↓ | |||||
23b | NHSO2 | H | 2 | pyrrol | ↓ | ↓ | ||||
23c | NHSO2 | H | 2 | morph | ||||||
23d | NHSO2 | 4-F | 2 | NMe2 | ↓ | ↑ | ||||
23e | NHSO2 | 4-F | 2 | pyrrol | ↓ | |||||
23f | NHSO2 | 4-F | 2 | morph | ↓ | ↑ | ||||
23g | NHSO2 | 4-F | 2 | diam | ↓ | ↑ | ||||
23h | NHSO2 | H | 2 | diam | ↓ | ↑ | ||||
24a | CH2CONH | H | 2 | NMe2 | ↓ | ↓ | ||||
24b | CH2CONH | H | 2 | pyrrol | ↓ | ↓ | ↓ | ↓ | ↓ | |
24c | CH2CONH | H | 2 | morph | ↓ | ↓ | ↓ | |||
24d | CH2CONH | H | 3 | NMe2 | ||||||
24e | CH2NHCO | 5-isoquinolyl | 2 | morph | ↓ | |||||
25a | CONH | 3-MeO-C6H4 | 2 | NMe2 | ↓ | ↓ | ↓ | |||
25b | CONH | 3-MeO-C6H4 | 2 | pyrrol | ↓ | ↓ | ↓ | |||
25c | CONH | 3-MeO-C6H4 | 2 | Morph | ↓ | ↓ | ↓ | |||
25d | CONH | 3-MeO-C6H4 | 3 | NMe2 | ↓ | ↑ | ↓ |
Bone marrow-derived macrophages preincubated for 18 h with 5 μg/mL of compounds were stimulated with 100 ng/mL LPS, 10 ng/mL BLP, or 0.01 μM CpG in the continued presence of the compounds. After 24 h, supernatants were collected and measured for their IL-12p40 and IL-6 content by ELISA. Arrows down (↓) indicate statistically significant (at least p < 0.05) down-regulation and arrows up (↑) statistically significant up-regulation of the levels of cytokine versus control; blank squares = no significant change. Abbreviations used in structural formulas: ‘coumarin’ = (7-methoxy-2-oxo-2H-chromen-4-yl)methyl; diam = N,N,N-1,1,2-tetramethylethylenediamino2-Me-but = 2-methylbutylamino; 4-Me-pip = 4-methylpiperazinyl; morph = morpholino; 3-OH-n-propyl = 3-hydroxypropylamino; pyrrol = pyrrolidino; stilbenyl = 1-(4-[(E)-2-phenylethyl]benzyl; thiomorph = thiomorpholino.